Kryddad's Disease (named after Courtney Kryddad, responsible for the first studies performed) is a chronic respiratory illness of the lungs. It is characterized by a persistent burning sensation within the chest, spreading into the esophageal region. Prior to the advancements in treatment research in 2072 by Pestläkare, it was regarded as being a terminal disease with a life expectancy of approximately 10 years following initial diagnosis.

Diagram of the affected area.

Since the development of breakthrough treatment, with proper management patients are expected to be able to live full lives with only minor setbacks.